The VarA-CsrA regulatory pathway influences cell shape in Vibrio cholerae.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
03 2022
Historique:
received: 07 01 2022
accepted: 11 03 2022
revised: 07 04 2022
pubmed: 29 3 2022
medline: 12 4 2022
entrez: 28 3 2022
Statut: epublish

Résumé

Despite extensive studies on the curve-shaped bacterium Vibrio cholerae, the causative agent of the diarrheal disease cholera, its virulence-associated regulatory two-component signal transduction system VarS/VarA is not well understood. This pathway, which mainly signals through the downstream protein CsrA, is highly conserved among gamma-proteobacteria, indicating there is likely a broader function of this system beyond virulence regulation. In this study, we investigated the VarA-CsrA signaling pathway and discovered a previously unrecognized link to the shape of the bacterium. We observed that varA-deficient V. cholerae cells showed an abnormal spherical morphology during late-stage growth. Through peptidoglycan (PG) composition analyses, we discovered that these mutant bacteria contained an increased content of disaccharide dipeptides and reduced peptide crosslinks, consistent with the atypical cellular shape. The spherical shape correlated with the CsrA-dependent overproduction of aspartate ammonia lyase (AspA) in varA mutant cells, which likely depleted the cellular aspartate pool; therefore, the synthesis of the PG precursor amino acid meso-diaminopimelic acid was impaired. Importantly, this phenotype, and the overall cell rounding, could be prevented by means of cell wall recycling. Collectively, our data provide new insights into how V. cholerae use the VarA-CsrA signaling system to adjust its morphology upon unidentified external cues in its environment.

Identifiants

pubmed: 35344548
doi: 10.1371/journal.pgen.1010143
pii: PGENETICS-D-22-00020
pmc: PMC8989286
doi:

Substances chimiques

Bacterial Proteins 0
Peptidoglycan 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010143

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101824/Z/13/Z
Pays : United Kingdom
Organisme : Howard Hughes Medical Institute
ID : 55008726
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Microbiology (Reading). 2011 Jun;157(Pt 6):1620-1628
pubmed: 21393367
Sci Rep. 2018 Jul 2;8(1):9892
pubmed: 29967470
PLoS Genet. 2012;8(6):e1002778
pubmed: 22737089
BMC Microbiol. 2010 May 28;10:155
pubmed: 20509862
Appl Environ Microbiol. 2007 Jun;73(11):3705-14
pubmed: 17449702
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Biochim Biophys Acta. 1973 Sep 15;321(1):369-81
pubmed: 4584395
Pathog Dis. 2018 Feb 1;76(1):
pubmed: 29315383
Nucleic Acids Res. 1999 Jan 1;27(1):29-34
pubmed: 9847135
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2524-9
pubmed: 14983042
Nat Rev Microbiol. 2020 Aug;18(8):446-460
pubmed: 32424210
Mol Microbiol. 2005 Nov;58(4):1186-202
pubmed: 16262799
Microbiol Mol Biol Rev. 2015 Jun;79(2):193-224
pubmed: 25833324
PLoS Pathog. 2006 Sep;2(9):e97
pubmed: 17002496
Mol Microbiol. 2008 Jan;67(2):241-53
pubmed: 18047567
J Bacteriol. 2002 Dec;184(23):6434-6
pubmed: 12426329
J Bacteriol. 1998 Feb;180(4):773-84
pubmed: 9473029
J Bacteriol. 2014 Nov;196(22):3937-48
pubmed: 25182499
Gene. 2002 Aug 21;296(1-2):179-85
pubmed: 12383515
Mol Microbiol. 2019 Jul;112(1):280-301
pubmed: 31070821
Nat Rev Microbiol. 2019 Jun;17(6):371-382
pubmed: 30944413
Science. 2009 Sep 18;325(5947):1552-5
pubmed: 19762646
Front Microbiol. 2019 Apr 17;10:793
pubmed: 31057510
Microb Ecol. 1982 Dec;8(4):313-23
pubmed: 24226049
BMC Microbiol. 2015 Sep 16;15:180
pubmed: 26376921
Front Microbiol. 2019 Mar 28;10:500
pubmed: 30984120
Nat Microbiol. 2016 Jun 20;1(7):16077
pubmed: 27572972
Mol Microbiol. 2018 Sep;109(6):826-844
pubmed: 29995990
PLoS Pathog. 2012;8(3):e1002602
pubmed: 22457624
Nucleic Acids Res. 2018 Nov 16;46(20):10619-10634
pubmed: 30102403
Science. 2015 Jan 2;347(6217):63-7
pubmed: 25554784
Sci Adv. 2020 Jul 22;6(30):eabb5614
pubmed: 32832672
J Vis Exp. 2012 Oct 08;(68):
pubmed: 23093249
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
J Bacteriol. 2009 Jan;191(2):494-505
pubmed: 18996994
EMBO J. 2016 May 2;35(9):991-1011
pubmed: 27044921
Science. 2005 Dec 16;310(5755):1824-7
pubmed: 16357262
PLoS Pathog. 2013;9(12):e1003800
pubmed: 24385900
PLoS Genet. 2016 May 13;12(5):e1006032
pubmed: 27176226
Clin Microbiol Rev. 2002 Oct;15(4):757-70
pubmed: 12364378
Nat Commun. 2017 Nov 17;8(1):1596
pubmed: 29150605
Microbiol Spectr. 2018 Mar;6(2):
pubmed: 29573256
J Biol Chem. 1988 Jul 25;263(21):10088-95
pubmed: 3292521
Gene. 1991 Dec 20;109(1):167-8
pubmed: 1661697
Plasmid. 2010 Nov;64(3):186-95
pubmed: 20709100
mBio. 2015 Aug 04;6(4):e01064
pubmed: 26242626
Cell Rep. 2020 Apr 28;31(4):107578
pubmed: 32348759
mBio. 2021 Feb 2;12(1):
pubmed: 33531387
PLoS Genet. 2017 Aug 21;13(8):e1006978
pubmed: 28827812
mSphere. 2016 May 25;1(3):
pubmed: 27303743
Infect Immun. 1998 Dec;66(12):5854-61
pubmed: 9826365
Microbiol Resour Announc. 2018 Dec 13;7(23):
pubmed: 30574591

Auteurs

Leonardo F Lemos Rocha (LF)

Laboratory of Molecular Microbiology, Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Katharina Peters (K)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Jacob Biboy (J)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Jamie S Depelteau (JS)

Microbial Sciences, Institute of Biology, Leiden University, Leiden, The Netherlands.

Ariane Briegel (A)

Microbial Sciences, Institute of Biology, Leiden University, Leiden, The Netherlands.

Waldemar Vollmer (W)

Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Melanie Blokesch (M)

Laboratory of Molecular Microbiology, Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH